Fundz

LuminUltra completes acquisition of Legionella Testing Business from Genomadix

PRIVATESep 09, 2024

Acquiring Company

LuminUltra

Acquired Company

Genomadix

FrederictonOttawaHealth CareWaterresearchBiotechnologyHealth CareMedical Device

Description

LuminUltra, the global leader in applied molecular diagnostics, has acquired the legionella testing business assets of Genomadix Inc. This strategic acquisition broadens LuminUltra's portfolio of molecular testing solutions, enabling rapid identification and quantification of microbes in water systems. It also empowers LuminUltra to develop and commercialize additional assays and test methods globally using the Genomadix Cube™ qPCR Platform.

Quick answer

LuminUltra is acquiring Genomadix, announced September 9, 2024. LuminUltra is based in Fredericton, New Brunswick, Canada.

How much did LuminUltra pay for Genomadix?
The deal value was not disclosed.
What does LuminUltra do?
LuminUltra is a global leader in applied molecular diagnostics, operating at the nexus of food, energy and water systems.
Where are LuminUltra and Genomadix based?
LuminUltra is based in Fredericton, New Brunswick, Canada. Genomadix is based in Ottawa, Ontario, Canada.
Who are the decision-makers at LuminUltra?
Fundz holds 1 contact at LuminUltra. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Other recent acquisitions in Water and research

Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.

Who to call at LuminUltra, and when

When LuminUltra changes hands, the new owners review vendors, systems and leadership. That is when the door opens.

  • An alert the day LuminUltra raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at LuminUltra, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at LuminUltra. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

LuminUltra

Location

520 King St

Fredericton, New Brunswick, Canada

About

LuminUltra is a global leader in applied molecular diagnostics, operating at the nexus of food, energy and water systems. Its testing technologies, services and scientific expertise help industries turn microbial uncertainty into confident action. Founded in 1995 and headquartered in Canada, LuminUltra serves customers in over 80 countries. Backed by XPV Water Partners, the company is driving global growth through innovation, strategic acquisitions and a commitment to delivering confidence in every count.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment LuminUltra makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Pat
Likely contact at this company
••••••••@••••••••

See Pat's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for LuminUltra's next move

Learn about Strategic plan

Frequently asked

Who acquired Genomadix?

Genomadix was acquired by LuminUltra, based in Fredericton. The deal was reported on September 9, 2024. LuminUltra is a global leader in applied molecular diagnostics, operating at the nexus of food, energy and water systems. LuminUltra is privately held and operates in Health Care.

When did LuminUltra acquire Genomadix?

LuminUltra's acquisition of Genomadix was reported on September 9, 2024. LuminUltra, the global leader in applied molecular diagnostics, has acquired the legionella testing business assets of Genomadix Inc. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.

What does Genomadix do?

Genomadix Inc. is a pioneer in real-time qPCR point of need technology. It is based in Ottawa, Canada, and specializes in molecular diagnostic instruments for precision medicine genotyping. It is privately held, operating in Biotechnology, and is based in Ottawa.

This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.